Tenaya Therapeutics, Inc. (TNYA)
0.8573
-0.08
(-8.31%)
USD |
NASDAQ |
May 15, 16:00
0.835
-0.02
(-2.60%)
Pre-Market: 09:18
Tenaya Therapeutics Total Assets (Quarterly) : 135.07M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 17.43M |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Krystal Biotech, Inc. | 1.397B |
| Vericel Corp. | 485.63M |
| Anavex Life Sciences Corp. | 132.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.88M |
| Shareholders Equity (Quarterly) | 106.19M |
| Debt to Equity Ratio | 0.0953 |
| Current Ratio | 5.754 |
| Net Debt Paydown Yield | 0.46% |